Romain Loyon
6PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.Myriam Ben Khelil, Maxime Fredon, Nawfel Adib
|Jan 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial.Laurie Spehner, Emeline Orillard, Antoine Falcoz
|Apr 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy.Valentine De Castro, Jeanne Galaine, Romain Loyon
|Jan 11, 2022
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy.Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued
|Aug 03, 2016
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.Jeanne Galaine, Guillaume Kellermann, Yves Guillaume
|May 29, 2016
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.Romain Loyon, Emilie Picard, Olivier Mauvais
Pageof 1
Frequent Collaborators
3 joint publications
Olivier Adotévi
2 joint publications
Virginie Mougey
2 joint publications
Marie Kroemer
2 joint publications
Myriam Ben Khelil
2 joint publications
Yann Godet
1 joint publications
Olivier Mauvais
1 joint publications
Nathalie Chaput
1 joint publications
Christophe Borg
1 joint publications
Romain Boidot
1 joint publications
Marine Jary
